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Background
The enzyme indoleamine 2,3-dioxygenase (IDO) converts
the amino acid tryptophan (Trp) to kynurenine (Kyn).
IDO, which shares many functional similarities with
iNOS [1], is also induced in sepsis [2]. Here, we investi-
gated whether IDO plays a role in human septic shock and
mouse endotoxemia akin to iNOS.
Materials and methods
Patients (n = 16) with septic shock had IDO activity
assessed (expressed as the ratio of Kyn to Trp) and the
severity of their hypotension determined (expressed by
inotrope requirement) during the course of illness. Nor-
mal and blood pressure-matched controls were also stud-
ied. Septic shock was induced in wild type and IDO-/-
mice, and the effect of 1-methyl-tryptophan (1 MT, a com-
petitive inhibitor of IDO) on blood pressure was deter-
mined. In animal studies, IDO expression and activity was
assessed by IHC in resistance vessels and plasma Kyn,
respectively. The direct vascular effect of Trp and Kyn was
determined by vessel functional studies on mouse aortic
rings.
Results
Patients' inotrope requirement correlated with IDO activ-
ity (p < 0.001). IDO activity increased by up to 9-fold with
sepsis and was significantly higher than in the two control
groups (Figure 1). In mice, endotoxemia led to hypoten-
sion, endothelial IDO expression in resistance vessels, and
increased IDO activity. In both IDO-/- and the 1MT-pre-
treated animals, hypotension was attenuated significantly
compared to wild-type controls (Figure 2). Similarly,
administration of 1 MT to hypotensive mice restored
blood pressure to normal. Kyn dose-dependently dilated
mouse aortic rings, whereas Trp only dilated arteries from
septic mice when IDO was expressed. Trp metabolites of
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the Kyn pathway other than Kyn were not vasoactive. Sep-
arate mechanistic studies indicated that Kyn relaxed blood
vessels through activation of sGC and adenylate cyclase.
Conclusion
This study shows a significant correlation between IDO
activity and hypotension in human septic shock, and that
Kyn may act as a previously unrecognized and important
vasodilator contributing to hypotension in sepsis. Inhibit-
ing IDO in humans may provide a novel therapeutic tar-
get for the treatment of septic shock.
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Drop in blood pressure in mice.